Are academic drug discovery efforts receiving more recognition with declining industry efficiency?

Expert Opin Drug Discov. 2019 Jul;14(7):605-607. doi: 10.1080/17460441.2019.1596080. Epub 2019 Mar 26.

Authors

Justin S Bryans¹, Catherine A Kettleborough¹, Roberto Solari²

Affiliations

¹ a LifeArc , Open Innovation Campus , Stevenage , UK.
² b Faculty of Medicine , National Heart & Lung Institute, Imperial College , London , UK.

PMID: 30907161
DOI: 10.1080/17460441.2019.1596080

No abstract available

Keywords: Academia-Pharma; drug discovery; not-for-profit; recognition.

Publication types

Editorial

MeSH terms

Cooperative Behavior
Drug Discovery / organization & administration*
Drug Industry / organization & administration*
Humans
Intersectoral Collaboration
Universities / organization & administration*